ABAli-Reza Biglarnia

Ali-Reza Biglarnia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali-Reza Biglarnia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Amir Sedigh

    Department of Transplantation, Surgical Sciences, Uppsala University Hospital Uppsala University Uppsala, Sweden [ protected

    1 shared publication
  • Anders Magnusson

    Department of Transplantation, Surgical Sciences, Uppsala University Hospital Uppsala University Uppsala, Sweden [ protected

    1 shared publication
  • Bengt von Zur-Mühlen

    Department of Transplantation, Surgical Sciences, Uppsala University Hospital Uppsala University Uppsala, Sweden [ protected

    1 shared publication
  • Bo Nilsson

    Department of Immunology, Genetics, and Pathology (IGP), Rudbeck Laboratory C5:3, Uppsala University, Uppsala, Sweden

    1 shared publication
  • Erik Larsson

    Department of Transplantation, Surgical Sciences, Uppsala University Hospital Uppsala University Uppsala, Sweden [ protected

    1 shared publication
  • Gunnar Tufveson

    Department of Transplantation, Surgical Sciences, Uppsala University Hospital Uppsala University Uppsala, Sweden [ protected

    1 shared publication

Latest Publications

  • Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective

    by Ali-Reza Biglarnia, Kristina N. Ekdahl, Bo Nilsson

    The humoral barrier in transplant biology is the result of preformed donor-specific antibodies (DSAs), directed either against human leukocyte antigens (HLA) or non-HLA antigens such as blood group (ABO) molecules. The term “sensitization” applies to patients carrying these antibodies. Transplantation is widely accepted as a life-saving opportunity for patients with terminal end-organ disease. However, in sensitized patients, transplant outcome is hampered by antibody-mediated rejection (AMR) as a consequence of DSA exposure. Furthermore, sensitized patients have limited access to “matched” organs from the both living and deceased donor pool. Considering the crucial role of the complement system in the pathophysiology of AMR and the availability of complement intervention therapeutics, there is a growing interest in complement-targeting strategies. This review highlights the emerging importance of monitoring and modulation of the complement system in the context of enabling transplantation across humoral incompatibility in sensitized recipients with preformed anti-HLA or natural anti-ABO antibodies. It also discusses the significance of the complement system in the induction of accommodation and further emphasizes current and future perspectives of novel complement therapeutics.


  • Utilization of Small Pediatric Donors Including Infants for Pancreas and Kidney Transplantation

    by Ali-Reza Biglarnia, William Bennet, Thomas Nilsson, Erik Larsson, Anders Magnusson, Shinji Yamamoto, Tomas Lorant, Amir Sedigh, Bengt von Zur-Mühlen, Lars Bäckman, et al.